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Aim: To investigate the mechanisms of cytotoxic activity and pro-/antioxidant effect of lactoferrin on hormone receptor-positive 
and receptor-negative breast cancer cells in vitro. Materials and Methods: The study was performed on receptor-positive (MCF-7, 
T47D) and receptor-negative (MDA-MB-231, MDA-MB-468) human breast cancer cell lines. Immunocytochemical staining, 
flow cytometry, low-temperature electron paramagnetic resonance, and the Comet assay were used. Results: Upon treatment 
with lactoferrin, the increased levels of reactive oxygen species (ROS) (p < 0.05), NO generation rate by inducible NO-synthase 
(p < 0.05) and the level of “free” iron (p < 0.05) were observed. Moreover, the effects of lactoferrin were more pronounced 
in receptor-negative MDA-MB-231 and MDA-MB-468 cells. These changes resulted in increased expression of proapoptotic 
Bax protein (p < 0.05), reduced expression of the antiapoptotic Bcl-2 protein (p < 0.05) and level of not-oxidized mitochondrial 
cardiolipin (1.4–1.7-fold, p < 0.05). This, in turn, caused an increase in the percentage of apoptotic cells (by 14–24%, p < 0.05). 
Cytotoxic effects of lactoferrin were accompanied by an increase in the percentage of DNA in the comet tail and blocking cell cycle 
at G2/M phase, especially in receptor-negative cell lines. Conclusion: The study showed that exogenous lactoferrin causes a viola-
tion of an antioxidant balance by increasing the level of ROS, “free” iron and NO generation rate, resalting in the blocking of cell 
cycle at G2/M-phase and apoptosis of malignant cells.
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Breast cancer (BC) is a heterogeneous disease that 
varies by the morphological and molecular structure 
as well as by the clinical course, and therefore requires 
different approaches to diagnosis and treatment. 
To date, the expansion of knowledge about the role 
of metalloproteins in malignant transformation and 
tumor progression as important components of me-
tabolism is a great interest. In this respect explora-
tion of iron metabolism disorders in cancer patients 
become increasingly relevant in recent years [1–3]. 
The role of such violations in the tumorigenesis 
is already proven by clinical and experimental studies. 
There is evidence that the concentration of iron and 
iron-regu lating proteins correlates with tumor ag-
gressiveness of BC [4]. Among the least studied iron-
containing proteins is lactoferrin (LF) — a protein with 
a unique set of biological properties of different nature. 
An important feature of LF is its ability to bind to nucleic 
acids and to regulate cell cycle, cell proliferative acti-
vity, and affect the oxidant/antioxidant balance in the 
cells. The synthesis and secretion of LF may be con-
stitutional (e.g., secretory glands) or controlled by sex 
hormones [5].
Nowadays the search and development of means 
of drug therapy with antioxidant properties is per-
formed worldwide. Experimental studies have shown 
that natural antioxidant proteins (ceruloplasmin, su-
peroxide dismutase (SOD), and alkaline phosphatase) 
have the highest activity compared with synthetic 
analogs. However, in modern oncology practice, only 
ceruloplasmin-based drugs are used.
The lack of studies aimed at assessing the impact 
of LF on the growth of malignant tumors, because of its 
ability under certain conditions to exercise prooxidative 
properties is one of the reasons why LF is not applied 
in practice. The existence of functionally different 
phenotypic and molecular genetic characteristics 
of BC cells with different biological aggressiveness 
is the basis for the development of methods for selec-
tive therapeutic intervention, which should be based 
on the results of experimental LF studies. Thus, our 
aim was to investigate the mechanisms of cytotoxic 
activity and pro/antioxidant effect of LF on hormone 
receptor-positive and -negative BC cells.
MATERIALS AND METHODS
Cell culture. Hormone-positive MCF-7 and T47D and 
hormone-negative MDA-MB-231 and MDA-MB-468 cell 
lines were used in our study. Cells were provided by the 
Bank of Cell Lines of Human and Animal Tissues 
at R.E. Kavetsky Institute of Experimental Patho logy, 
Oncology, and Radiobiology of NAS of Ukraine. All cells 
were cultured in DMEM (Sigma, USA), supplemented 
with recombinant human insulin (Life Technologies, 
USA; 0.01 mg/ml) and 10% fetal bovine serum (Sigma 
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Aldrich, USA). All cultures were incubated in humidified 
atmosphere with 5% CO2 at 37 °C.
Measurement of cell viability, using the MTT as-
say was performed as described previously [6]. The 
cytotoxic effect of exogenous LF, wich was synthesized 
at the State Scientific Institution “Institute of Physio-
logy” (Minsk, Republic of Belarus) was measured in the 
dose range of 2–300 μg/ml.
Immunocytochemical study of the expression 
of apoptosis regulators in BC cells was performed 
using monoclonal mouse anti-human Bcl-2 (clone 
124) and polyclonal rabbit anti-human Bax antibo dies 
(DakoCytomation, Denmark). For the detection reac-
tion visualization, UltraVision Quanto Detection System 
HRP DAB (Thermo Fisher Scientific, USA) was used.
Cells for immunocytochemical studies were 
grown on glass cover slips, fixed in the cooled mix-
ture of methanol:acetone (1:1) at –20 °C for 120 min, 
washed in PBS and incubated with 1% BSA for 20 min. 
Primary monoclonal antibodies were diluted in the 
blocking buffer and kept at a room temperature for one 
hour, followed by incubation with UltraVision Quanto De-
tection System for 10 and 15 min; after the washing, the 
immune reaction was visualized by using DAB Quanto. 
When immunocytochemical reactions were completed, 
the cells were stained by Mayer’s hematoxylin for 
10–15 s and placed in Faramount Aqueous Mount-
ing Medium (DakoCytomation, Denmark). Evaluation 
of the results was carried out in 3 visual fields by light 
microscopy (x 1000, oil immersion) using the classical 
H-Score method:
S = 1×N1+ + 2×N2+ + 3×N3+,
where S is “H-Score” index, N1+, N2,+ and N3+ are 
numbers of cells with low, medium or high levels 
of marker expression.
Low -temperature electron paramagne-
tic resonance. The level of “free” iron and rate 
of NO gene ration by inducible NO-synthase were 
estimated by low-temperature electron paramagnetic 
resonance (EPR). To determine the level of “free” iron, 
samples were kept during spectra recording at liquid 
nitrogen temperature (77 K). For low-temperature EPR 
the following parameters were used: stripe width was 
1525 G, frequency — 9.15 GHz, microwave power — 
40 mW, amplitude modulation — 10.0 G, frequency 
modulation — 100 kHz. g-Factor was calculated using 
a standard formula:
g = hν/βH, 
where h is Plank’s constant; ν — frequency, 
β — Bohr’s magneton; H — external magnetic field 
in resonance.
The evaluation of speed of NO generating by induc-
ible NO-synthase in BC cells was conducted at room 
temperature using technology SpinTrap in the tem-
perature of liquid nitrogen (77 K). The level of NO was 
determined using a diethyldithiocarbomate spin trap 
(Sigma, USA) and EPR technology. The generation 
of NO was registered during 5 min followed by ces-
sation of NO generation by liquid nitrogen. The levels 
of NO were calculated in nmol/2.5•105 cells.
Genotoxic activity of LF assessment was per-
formed using a standard classical method of alkaline 
gel electrophoresis of isolated cells (Comet assay) 
as described in [7]. After drying the samples were 
stained with acridine orange (Sigma Aldrich, USA; 
2 mg/ml). Microscopic analysis was performed using 
a fluorescent microscope MC 300x FS (Micros, Aus-
tria). For each analyzed specimens at least 100 “DNA-
comets”. Digital images were analyzed by the com-
puter program “CometScore” (TriTek Corp., USA).
Measurement of SOD. SOD activity was detected 
as described earlier [8]. Briefly, cells were homo genized 
in the glass homogenizer with 2 ml of 0.1 М PBS. After 
centrifugation at 3000 rpm for 20 min supernatant was 
analyzed for SOD activity using radiospectrometer 
ЕPR-1307 (ZEPS AN, Russia) at room temperature.
Flow cytometry. Determination of the reactive 
oxygen species (ROS), cardiolipin and glutathione 
content, the study of apoptosis and DNA status of cells 
were conducted using specific dyes for flow cyto metry 
on Beckman Coulter EPICS® XL Flow Cytometer (Beck-
man Coulter, USA). To study of ROS generation by flow 
cytometry CM-H2DCFDA dye (Thermo Fisher Scientif-
ic, USA) was used following the manufacturer’s recom-
mendations. Assessment of the content of glutathione 
in BC cells was performed using dye CellTracker™ 
GreenCMFDA dye (Thermo Fisher Scientific, USA), 
following the manufacturer’s recommendations. To vi-
sualize the distribution of cardiolipin in mitochondria 
acridine orange 10-nonyl bromide (NAO; Invitrogen, 
USA) dye was used as described in [9]. To determine 
the number of apoptotic cells the staining with An-
nexin A5-FITC Kit (Beckman Coulter, France) was used 
as described in [10]. Charts of density distribution 
of the studied parameters were analyzed using FCS 
Express V3 (De Novo Software, USA). DNA status was 
assessed using ModFit v3.2 software (Verity Software 
House, USA).
Statistical analysis. Experimental data were 
analyzed using the Student’s t-test. p-values less than 
0.05 were considered statistically significant. Statisti-
cal analysis of the obtained data was performed using 
the STATISTICA 6.0 software (Dell, USA).
RESULTS AND DISCUSSION
BC is a heterogeneous disease that varies 
by the morphological and molecular features as well 
as by the clinical course, and therefore requires dif-
ferent approaches to diagnosis and treatment. Know-
ledge about the role of metalloproteins in malignant 
transformation and tumor progression as important 
components of metabolism attaches great importance 
to date. In this respect in recent years become increas-
ingly relevant studying of disorders of iron metabolism 
and possibilities of its modification by exogenous 
agents [11]. LF is very perspective agent for this pur-
pose, because it is normal iron-regulating protein, 
possessing immune and antitumor activities [12].
We established more pronounced cytotoxic ac-
tivity of LF on receptor-negative MDA-MB-231 and 
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MDA-MB-468 cells compared to receptor-positive 
MCF-7 and T47D cells. As seen from the data present-
ed in Fig. 1, IC30 dose for MCF-7 and T47D cells was 
10 μg/ml, while for MDA-MB-231 and MDA-MB-468 cells 
the similar dose of exogenous LF caused the death 
of 45% and 40% of cells, respectively. The dose of LF, 
that causes death in 30% of the cells with negative 
receptor status, was 5 μg/ml. To study the molecular 
effects of LF we used IC30 doses; cells were treated 
with LF for 24 h.
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Fig. 1. Cytotoxic activity of exogenous LF on human BC cells 
with different receptor status
It is known that one of the main functions 
of LF is the regulation of the concentration of iron 
ions in the cells. Iron is a key element for the normal 
processes of proliferation and cell growth. Intra-
cellular iron is carefully maintained and controlled 
at a certain level by many mechanisms. It is known 
that cancer cells have a significant increase in iron 
content due to their enhanced metabolic and pro-
liferative needs [13]. On the other hand, the content 
of “free” iron in cancer cells may decrease because 
of its exhaustion, which also indicates an increased 
need for this element in cells that rapidly grow and 
divide. However, the excess iron can lead to the for-
mation of dangerous ROS, which creates conditions 
for the initiation and progression of tumors. Increased 
number of ROS also can be caused by any other cell 
response to stress. This is the adaptation to extreme 
conditions, in which ROS act as second messengers 
participating in signal transduction and activation 
of transcription factors of certain genes, including 
those encoding enzymes and antioxidants.
The physiological level and rate of generation 
of ROS in the cells are maintained at a constant level 
due to the existence of multi-antioxidant protection 
system. Higher concentrations of ROS due to shifting 
the balance between the processes of their formation 
and detoxification are a precondition for infringement 
of functional activity of cells and pathological pro-
cesses [14]. Therefore, the next series of experiments 
were aimed at studying changes on the level of “free” 
iron in LF-treated BC cells with different hormone 
receptor status.
We found a significant increase of “free” iron content 
after treatment of BC cells with LF (Fig. 2). Thus, in the 
treated receptor-positive MCF-7 and T47D cells, the 
levels of “free” iron increased to 1.7–1.9-fold and were 
0.98 ± 0.11•1016 spin/ml and 0.88 ± 0.1•1016 spin/ml. 
Treatment of MDA-MB-231 and MDA-MB-468 cells 
under similar conditions led to increased levels of 
“free” iron in 2.3–2.5-fold (see Fig. 2).
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Fig. 2. The levels of “free” iron in BC cells with different receptor 
status under the influence of exogenous LF. *р < 0.05 compared 
to untreated cells
Culvation of BC cells with exogenous LF also 
led to an increase in ROS generation (Fig. 3). Thus, 
in treated MCF-7 and T47D cells intracellular le-
vels of ROS increased by 2 times and amounted 
up to 3.32 ± 0.24 r. u. and 5.21 ± 0.67 r. u., respectively. 
Treatment of MDA-MB-231 and MDA-MB-468 cells 
with LF also led to an increase in intracellular levels 
of ROS at 1.76- and 1.63-fold, respectively.
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Fig. 3. The levels of ROS in BC cells with different receptor 
status under influence of exogenous LF. *р < 0.05 compared 
to untreated cells
During the study of NO generation speed by in-
ducible NO-synthase in BC cells after cultivation with 
LF, we established an increase of this indicator 
in all studied cell lines. As can be seen from the data 
presented in Fig. 4, in the hormone-responsible 
MCF-7 and T47D cells the rate of NO-generation 
by exogenous LF increased in 1.5–1.6-fold and 
amounted up to 271.75 ± 10.45 nmol/2.5•105 and 
256.70 ± 11.81 nmol/2,5•105, respectively. In recep-
tor-negative MDA-MB-231 and MDA-MB-468 cells 
NO generation rate raised of more than 90%.
Thus, LF treatment of receptor-positive and recep-
tor-negative BC cells resulted in oxidative stress. This 
is evidenced by the increase of “free” iron, intracellular 
levels of ROS, and NO generation speed by inducible 
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NO-synthase after LF treatment. The most serious 
violations of oxidative balance rates after LF effect 
we observed in receptor-negative BC cells.
There is evidence about LF ability to disrupt 
the mitochondrial membrane, which is associated 
with increased levels of ROS and release of cyto-
chrome C [15]. ROS oxidize polyunsaturated acyl 
chains of cardiolipin, which is a signal for triggering 
apoptosis [16]. As mentioned above, the system 
of glutathione is one of the most powerful intracellular 
antioxidative mechanisms. The thiol groups of gluta-
thione in the reduced state are in a high concentration 
in cells, which allows recovering disulfide bonds. The 
balance between restored and oxidized forms of glu-
tathione is an important parameter that determines 
the level of oxidative stress in cells [17].
Another powerful antioxidant enzyme is oxide-
reducing SOD that catalyzes the dismutation of O2– 
radicals and prevents the transformation of super-
oxide anion radicals into the hydroxyl radical. Also, 
SOD is an acceptor of free oxygen radicals, thereby 
preventing lipid and protein peroxidation. Normally 
the SOD supports basic concentration of superoxide 
radicals at a certain level, thereby protecting cells from 
damaging effect of O2– and hydroxyl radicals that can 
be generated from O2– and HO [18].
In our study, we tested the reduced form of gluta-
thione using dye CellTrackerGreen (CMFDA), which 
interacts with SH-groups of glutathione, by flow 
cyto metry. On Fig. 5 are represented typical histo-
grams of reduced glutathione in the BC cells. As can 
be seen from the data presented in Fig. 6, LF treat-
ment in a dose corresponding to IC30, for 24 h re-
sulted in a decrease in intracellular glutathione content 
in studied BC cell lines, indicating a transition of glu-
tathione in the oxidized state. The most significant 
decrease (in 4.3- and 2.3-fold) glutathione content 
was observed in MCF-7 and MDA-MB-468 cells. 
In the T47D and MDA-MB-231 cells the glutathione 
level decreased by 1.9- and 1.4-fold, respectively, 
and amounted to 3.57 ± 0.82 r. u. and 3.32 ± 0.45 r. u., 
respectively. Established differences in levels of glu-
tathione in MCF-7 and MDA-MB-468 cells are likely 
caused by the high proliferative activity of these cells.
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Fig. 6. The reduced glutathione levels in BC cells with different 
receptor status under influence of exogenous LF. *р < 0.05 com-
pared to untreated cells
LF treatment also led to reduced activity of SOD 
in 1.2–1.7-fold compared to baseline in all studied 
cell lines (Fig. 7).
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Fig. 7. SOD activity in BC cells with different receptor status 
under influence of exogenous LF. *р < 0.05 compared to un-
treated cells
According to the literature, one of the mechanisms 
of exogenous LF action is initiating apoptosis in malig-
nant cells [19]. Thus, Fujita et al. found that treatment 
of colorectal cancer cells with LF increases the expres-
sion of death receptor CD95 and proapoptotic Bax 
and Bid proteins [19]. We established that exposure 
to exogenous LF of studied BC cells caused cell death 
mainly by apoptosis. As it is shown in Table 1, under 
the influence of LF 25.5% and 22.6% of the MCF-7 and 
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Fig. 4. The rate of NO generation by inducible NO-synthase 
in human BC cells with different receptor status under influence 
of exogenous LF. *р < 0.05 compared to untreated cells
Fig. 5. Typical flow cytometry histograms of glutathione content 
in BC cells: a — untreated cells; b — LF-treated cells
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T47D cells, respectively, were in a state of apoptosis. 
The highest percentage of apoptotic cells under exoge-
nous LF treatment was observed in receptor-negative 
MDA-MB-468 and MDA-MB-231 cells (43.2 and 41.3%, 
respectively). Therefore, LF treatment resulted in an in-
crease of apoptotic cells in receptor-positive BC cells 
(by 14% in MCF-7 and 17% in T47D cells) as well as in re-
ceptor-negative BC cells (by 33% in MDA-MB-231 cells 
and 29% in MDA-MB-468 cells).
Table 1. Percentage of apoptotic cells in BC cell lines before and after 
LF treatment
Cell line Apoptotic cells, %Control After LF treatment
MCF-7 8.1 ± 3.1 25.5 ± 2.8*
T47D 8.7 ± 2.9 22.6 ± 3.2*
MDA-MB-231 10.6 ± 3.7 43.2 ± 2.7*
MDA-MB-468 12.2 ± 4.0 41.3 ± 3.8*
Note: *р < 0.05 compared to untreated cells.
Since it is known that a key role in the initiation 
of apoptosis belongs to cardiolipin — an essential 
phospholipid component of the mitochondria mem-
branes — on the next step we studied the changes 
in its content in the BC cells under the influence 
of exogenous LF. As can be seen from the data pre-
sented in Fig. 8, 24 h LF expose resulted in a decrease 
in NAO fluorescence intensity in all investigated cells 
lines. So, upon LF treatment the levels of non-oxidized 
cardiolipin in MCF-7 and T47D cells decreased by 1.6- 
and 1.7-fold, respectively. In MDA-MB-231 cells 
cardiolipin levels decreased 2.4-fold and amounted 
to 57.29 ± 7.65 r. u., whereas in MDA-MB-468 cell line 
cardiolipin levels decreased by 2.1-fold and amounted 
to 136.07 ± 74.20 r. u., indicating the development 
of oxidative stress. Unidirectional reducing of NAO 
fluorescence in the cells of all studied lines under the 
LF impact demonstrates the ability of LF to oxidize mi-
tochondrial cardiolipin. The most significant changes 
in cardiolipin content we observed in receptor-nega-
tive MDA-MB-231 and MDA-MB-468 cells.
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Fig. 8. The levels of not-oxidized mitochondrial cardiolipin 
in BC cells with different receptor status under the influence 
of exogenous LF. *р < 0.05 compared to untreated cells
We determined that the LF is able to initiate the 
apoptotic program in a more severe form in receptor-
negative cells not only due to the oxidation of cardioli pin, 
but also by influencing the level of expression of pro- 
and antiapoptotic proteins. Thus, in the LF-treated 
MCF-7 and T47D cells expression level of proapoptotic 
Bax protein increased by 10–13% to 223.4 ± 2.6 and 
187.3 ± 4.8 H-score points, respectively, while in the 
MDA-MB-231 and MDA-MB-468 cells expression level 
of Bax after LF treatment increased by 16–17% and 
amounted to 180.7 ± 3.8 and 167.4 ± 4.7 H-score 
points, respectively (Table 2). The study of the expres-
sion of antiapoptotic Bcl-2 protein after exogenous LF in-
fluence showed a decrease of Bcl-2 in cells of all studied 
lines (see Table 2). Thus, Bcl-2 expression in receptor-
positive BC cells after LF treatment decreased by 16–
18%, while the level of Bcl-2 in the MDA-MB-231 and 
MDA-MB-468 cells decreased at 21–23%.
Table 2. The levels of pro- and anti-apoptotic proteins in BC cells 
with different receptor status
Cell line
Protein level, H-score
Proapoptotic Bax protein Antiapoptotic Bcl-2 protein
Control After LF treatment Control
After LF  
treatment
MCF-7 195.1 ± 4.5 223.0 ± 2.6* 298.1 ± 2.1 252.0 ± 0.8*
T47D 165.0 ± 3.7 187.3 ± 4.8* 286.1 ± 5.8 240.2 ± 6.1*
MDA-MB-231 156.2 ± 2.8 180.0 ± 3.8* 258.0 ± 2.7 208.1 ± 3.6*
MDA-MB-468 142.1 ± 4.6 167.2 ± 4.7* 247.2 ± 3.1 190.4 ± 4.8*
Note: *р < 0.05 compared to untreated cells.
It is known that an important LF feature is its 
ability to bind to nucleic acids and thus affect the 
proliferative activity of cells. Also, LF is able to stop 
cell growth by modulating the expression and activity 
of G1 cyclin-dependent kinases and activation of trans-
cription [20, 21]. There are also reports of a possible 
genotoxic effect of LF. Given the above, the next step 
we investigated the changes of cell cycle in LF-treated 
BC cells. As seen from the data presented in Table 3, 
cytotoxic effects of LF followed by blocking cell cycle 
at G2/M phase, particularly in receptor-negative cells 
and 1.4–2.5-fold decrease in cell number in the syn-
thetic phase of the cell cycle of all studied BC cell lines. 
At the same time, we have confirmed the LF genotoxic 
action using the Comet assay. We identified a signifi-
cant increase (p < 0.05) the percentage of DNA in the 
comet tail in 1.9- and 2.3-fold, respectively, under the 
influence of LF in MDA-MB-468 and MDA-MB-231 cells 
with negative receptor status (Table 4).
Table 3. Cell cycle distribution of receptor-positive and receptor-negative 
BC cells
Cell line Control, % After LF treatment, %G1 G2 + M S G1 G2 + M S
MCF-7 51.4 ± 
2.8
11.8 ± 
1.3
36.8 ± 
3.6
72.6 ± 
3.1*
9.1 ± 
2.0
18.3 ± 
1.6*
T47D 55.3 ± 
4.1
19.8 ± 
3.4
24.9 ± 
2.6
71.2 ± 
2.9*
11.4 ± 
1.9*
17.4 ± 
2.1*
MDA-MB-231 51.2 ± 
4.8
27.5 ± 
4.2
21.3 ± 
1.8
76.6 ± 
4.2
13.9 ± 
0.4*
9.5 ± 
2.7*
MDA-MB-468 56.7 ± 
3.9
22.6 ± 
1.9
20.7 ± 
2.1
74.8 ± 
4.0*
17.3 ± 
0.7*
8.07 ± 
1.9*
Note: *р < 0.05 compared to untreated cells.
Table 4. Percentage of DNA in the comet tail of BC cells with different 
receptor status
Cell line Tail DNA, %Control After LF treatment
MCF-7 5.33 ± 1.41 9.80 ± 2.50
T47D 5.20 ± 1.10 9.70 ± 1.90
MDA-MB-231 6.10 ± 1.52 14.03 ± 2.11*
MDA-MB-468 5.80 ± 0.90 11.02 ± 1.90*
Note: *р < 0.05 compared to untreated cells.
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CONCLUSION
Exogenous LF causes the increase of ROS levels, 
speed of NO generation by inducible NO-synthase 
and the levels of “free” iron in BC cells. Moreover 
LF effects are more pronounced in receptor-negative 
MDA-MB-231 and MDA-MB-468 cells. Also, LF treat-
ment causes the decrease in the content of reduced 
glutathione. We also established the ability of LF to in-
crease the percentage of apoptotic cells and to re-
duce cardiolipin levels in mitochondria. This, in turn, 
leads to increased expression of proapoptotic Bax 
protein and reduction of the expression antiapop-
totic Bcl-2 protein. Cytotoxic effects of LF followed 
by blocking cell cycle at G2/M phase, particularly 
in receptor-negative cells this process was accompa-
nied by a decrease the number of cells in the synthetic 
phase of the cell cycle.
So, we can conclude that LF can be used as an exo-
genous modifier of such cancer features as oxidant/
antioxidant balance, apoptotic rates, and cell cycle 
progression. Our results demonstrated that LF could 
be considered as a promising agent, which can 
be used in low doses and the obtained data create the 
basis for further in vivo investigations.
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